You are in:Home/Publications/Ovarian Hyper-Stimulation Syndrome during Intracytoplasmic Sperm Injection procedure for Infertile Polycystic Ovary patients could be a Preventable Tragedy

Prof. Ayman ahmed abd elhamid shdid :: Publications:

Title:
Ovarian Hyper-Stimulation Syndrome during Intracytoplasmic Sperm Injection procedure for Infertile Polycystic Ovary patients could be a Preventable Tragedy
Authors: Ayman A. Abdelhamid and Ahmed Walid A. Morad
Year: 2012
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Ayman ahmed abd elhamid shdid_144_10987am0809_1047_1053_4.pdf
Supplementary materials Not Available
Abstract:

Objectives: To evaluate and compare the preventive efficacy and safety of bromocriptine tablets and calcium infusion on the frequency and severity of ovarian hyper-stimulation syndrome (OHSS) in polycystic ovary syndrome (PCOS) women assigned for intracytoplasmic sperm injection (ICSI). Patients & Methods: The current retro-prospective included 30 PCOS women (Group A) completed their ICSI program according to the protocol assigned for the prospective part of the study and developed OHSS and 60 patients randomly divided into 2 equal groups: Group B received bromocriptine 2.5 mg/day started on day of ovum pickup for 16 days and Group C included 30 patients received intravenous 10% calcium gluconate 10 ml in 200 ml saline on the day of ovum pickup and on days 1, 2 and 3 after ovum pickup. Ovarian stimulation program using gonadotrophine releasing hormone (GnRH)-agonist was started at the luteal phase and when at least two follicles had reached a diameter of ≥18 mm, rFSH was stopped, and a single subcutaneous bolus of 10,000 IU hCG was administered 36 hrs before the planned time of oocyte retrieval. The ICSI procedure was performed and a maximum of two embryos were transferred 3days after egg retrieval. Luteal support in the form of intravaginal progesterone was given daily from the day of oocyte retrieval for 16 days and was continued for up to12 weeks if pregnancy occurred. Outcome was defined as the frequency and severity of OHSS. Results: Ten patients (16.7%) in prospective part developed OHSS; 7 had mild and 3 patients had moderate manifestations with non-significant difference between both study groups as regards the frequency of OHSS and that of moderate OHSS. On contrary; 13 patients (43.3%) in the retrospective part developed OHSS with significantly higher frequency compared to the prospective part, irrespective to preventive therapy. Among those had OHSS in the retrospective part; 7 had mild and 5 had moderate manifestation and one patient developed severe manifestations necessitated hospitalization; an event that dose not occur in the prospective part. Concerning severity, there was significantly higher frequency of high severity grades among patients of the retrospective versus the prospective part of the study. Conclusion: Prevention of OHSS in PCOS women committing ART is feasible and safe provided proper patient selection was followed. The non-significant difference between both modalities of OHSS prevention as regards clinical pregnancy rate and both the frequency and severity of OHSS opened the way for patients' preference of the preventive modality and their general health status to be the selection guide.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus